Skip to main content
    P

    Purple Biotech (PPBT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.68
    +0.05 (+3.07%)

    Market Cap: $2.65M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Purple Biotech (PPBT) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Purple Biotech (PPBT) to earn -$5.73 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.01.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$5.73
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$1.01
    EPS consensus
    Fiscal year ending Dec 31, 2028
    -$0.15
    EPS consensus, revenue $6.50M

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$5.73-$5.73 to -$5.731N/AN/A1
    Dec 31, 2027-$1.01-$1.01 to -$1.011N/AN/A1
    Dec 31, 2028-$0.15-$0.15 to -$0.151$6.50M$6.50M to $6.50M1

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.65.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$5.73-$5.31-$5.31-$5.31-$1.65N/A
    Fiscal year ending Dec 31, 2027-$1.01-$0.88-$0.88-$0.88-$0.64N/A

    Frequently Asked Questions About PPBT

    What is the PPBT stock forecast?

    Consensus analyst estimates put Purple Biotech's EPS at -$5.73 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from PPBT next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$5.73, with estimates from -$5.73 to -$5.73 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.01, with estimates from -$1.01 to -$1.01 from 1 analyst.

    What revenue do analysts expect from Purple Biotech next year?

    For the fiscal year ending Dec 31, 2028, the consensus revenue estimate is $6.50M, with estimates from $6.50M to $6.50M.

    How many analysts cover PPBT?

    1 analyst estimates EPS for Purple Biotech for the fiscal year ending Dec 31, 2026.